- Home
- XNCR vs PAXS Comparison
XNCR vs PAXS Comparison
Compare XNCR & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | PAXS |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 721.4M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XNCR | PAXS |
|---|---|---|
| Price | $11.29 | $14.83 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.89 | N/A |
| AVG Volume (30 Days) | ★ 560.6K | 165.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $13.63 |
| 52 Week High | $18.69 | $16.56 |
Technical Indicators
Market Signals| Indicator | XNCR | PAXS |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 20.91 |
| Support Level | $11.02 | $14.58 |
| Resistance Level | $12.58 | $15.24 |
| Average True Range (ATR) | 0.89 | 0.25 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 16.33 | 1.83 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.